These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8684741

  • 1. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J, Hauth JC.
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [Abstract] [Full Text] [Related]

  • 2. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS, Savage K, Lincoln T, Owen J.
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [Abstract] [Full Text] [Related]

  • 3. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination.
    Owen J, Hauth JC.
    J Matern Fetal Med; 1999 Jul; 8(2):48-50. PubMed ID: 10090490
    [Abstract] [Full Text] [Related]

  • 4. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
    Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM.
    Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
    [Abstract] [Full Text] [Related]

  • 5. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.
    Jain JK, Mishell DR.
    N Engl J Med; 1994 Aug 04; 331(5):290-3. PubMed ID: 8022438
    [Abstract] [Full Text] [Related]

  • 6. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL, Valley MT, Rayburn WF, Carey JC.
    J Reprod Med; 1997 Aug 04; 42(8):497-500. PubMed ID: 9284011
    [Abstract] [Full Text] [Related]

  • 7. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG, Senöz S, Urkütür M, Batioglu S, Gökmen O.
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov 04; 69(2):97-102. PubMed ID: 8902440
    [Abstract] [Full Text] [Related]

  • 8. Second-trimester membrane rupture. Abortion induced with prostaglandin E2 after oxytocin failure.
    Atad J, Hallak M, Fruchter O, Borenstein J, Abramovici H.
    J Reprod Med; 1997 Sep 04; 42(9):581-4. PubMed ID: 9336755
    [Abstract] [Full Text] [Related]

  • 9. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL, Bolognese RJ.
    J Reprod Med; 1975 Feb 04; 14(2):43-6. PubMed ID: 1113258
    [Abstract] [Full Text] [Related]

  • 10. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH.
    J Obstet Gynaecol; 2003 Jul 04; 23(4):407-11. PubMed ID: 12881083
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial of prostaglandin E2 gel and extra-amniotic saline infusion with high dose oxytocin for cervical ripening.
    Sharami SH, Milani F, Zahiri Z, Mansour-Ghanaei F.
    Med Sci Monit; 2005 Aug 04; 11(8):CR381-6. PubMed ID: 16049380
    [Abstract] [Full Text] [Related]

  • 12. Vaginal PGE2 and intraamniotic PGF2 alpha for the termination of second trimester pregnancy.
    Farmakides G, Schulman H, Fayemi A, Fleischer A, Mitchell J, Blattner P.
    Acta Chir Hung; 1986 Aug 04; 27(3):137-42. PubMed ID: 3469840
    [Abstract] [Full Text] [Related]

  • 13. Midtrimester pregnancy termination: a randomized trial of prostaglandin E2 versus concentrated oxytocin.
    Owen J, Hauth JC, Winkler CL, Gray SE.
    Am J Obstet Gynecol; 1992 Oct 04; 167(4 Pt 1):1112-6. PubMed ID: 1384335
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 suppositories as a second-trimester abortifacient.
    Rakhshani R, Grimes DA.
    J Reprod Med; 1988 Oct 04; 33(10):817-20. PubMed ID: 3193412
    [Abstract] [Full Text] [Related]

  • 15. Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin F2 alpha gel and prostaglandin E2 pessary.
    Majoko F, Zwizwai M, Nyström L, Lindmark G.
    Cent Afr J Med; 2002 Oct 04; 48(11-12):123-8. PubMed ID: 14562597
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA, Hannah ME, Chitayat D, Thomas M, Winsor E, Ferris LE, Einarson TR, Seaward PG, Ryan G, Willan AR, Windrim R.
    Am J Obstet Gynecol; 2004 Mar 04; 190(3):755-62. PubMed ID: 15042010
    [Abstract] [Full Text] [Related]

  • 17. Induction of labour: a comparison between controlled-release dinoprostone vaginal pessary (Cervidil) and dinoprostone intravaginal gel (Prostin E2).
    Kho EM, Sadler L, McCowan L.
    Aust N Z J Obstet Gynaecol; 2008 Oct 04; 48(5):473-7. PubMed ID: 19032662
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA, Hanson FW.
    Surg Gynecol Obstet; 1983 May 04; 156(5):585-8. PubMed ID: 6573807
    [Abstract] [Full Text] [Related]

  • 19. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise.
    Debby A, Sagiv R, Girtler O, Sadan O, Glezerman M, Golan A.
    Arch Gynecol Obstet; 2003 Oct 04; 268(4):301-3. PubMed ID: 14504874
    [Abstract] [Full Text] [Related]

  • 20. Mid-trimester abortion using hypertonic saline or prostaglandin E2 gel: an analysis of efficacy and complications.
    Herabutya Y, O-Prasertsawat P.
    J Med Assoc Thai; 1994 Mar 04; 77(3):148-52. PubMed ID: 7798849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.